Ameriprise’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-44,919
| Closed | -$807K | – | 3899 |
|
|
2023
Q3 | $807K | Sell |
44,919
-42,947
| -49% | -$771K | ﹤0.01% | 3233 |
|
|
2023
Q2 | $1.79M | Buy |
87,866
+1,035
| +1% | +$21.1K | ﹤0.01% | 2929 |
|
|
2023
Q1 | $1.89M | Buy |
86,831
+34,426
| +66% | +$749K | ﹤0.01% | 2872 |
|
|
2022
Q4 | $1.62M | Sell |
52,405
-885
| -2% | -$27.4K | ﹤0.01% | 2902 |
|
|
2022
Q3 | $1.36M | Sell |
53,290
-1,488
| -3% | -$38K | ﹤0.01% | 2965 |
|
|
2022
Q2 | $1.11M | Sell |
54,778
-599
| -1% | -$12.2K | ﹤0.01% | 3073 |
|
|
2022
Q1 | $1.37M | Buy |
55,377
+12,902
| +30% | +$319K | ﹤0.01% | 3074 |
|
|
2021
Q4 | $1.48M | Buy |
+42,475
| New | +$1.48M | ﹤0.01% | 3076 |
|
|
2020
Q3 | – | Sell |
-12,469
| Closed | -$279K | – | 3724 |
|
|
2020
Q2 | $279K | Buy |
+12,469
| New | +$279K | ﹤0.01% | 3382 |
|